Baxter Intl (NYSE:BAX) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.44, missing the consensus estimate of $0.53 by $0.09 per share. Revenue came in at $3.0B, beating the estimate of $2.8B.
Baxter Intl's stock moved following the earnings release. The stock currently trades at $19.79 with a market capitalization of $9.7B.


